ReShape Lifesciences Inc Stock News

One of the biggest movers in today's session, Reshape Lifesciences (NASDAQ: RSLS ) is absolutely skyrocketing. At the time of writing, RSLS stock has surged an impressive 150% in today's session al

Reshape Lifesciences (NASDAQ: RSLS ) stock is rocketing higher on Friday as a filing mixup shines a light on the company's shares. According to a filing with the U.S. Securities and Exchange Commissio

ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Paula Schwartz - Managing Director-Rx Communications Group Paul Hickey - Pre

Conference Call to be Held at 8:00 am ET on Monday, November 14, 2022 Conference Call to be Held at 8:00 am ET on Monday, November 14, 2022

SAN CLEMENTE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul

ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Michael Miller - Rx Communications, Investor Relations Paul Hickey - President

Conference Call to be Held at 4:30 pm ET on Monday, August 15 , 2022 Conference Call to be Held at 4:30 pm ET on Monday, August 15 , 2022

ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q1 2022 Earnings Conference Call May 23, 2022 8:30 AM ET Company Participants Michael Miller - Rx Communications, Investor Relations Bart Bandy - President and

Webcast to be Held at 8:30 am ET on Monday, May 23, 2022 Webcast to be Held at 8:30 am ET on Monday, May 23, 2022

Management will also Present to Members of the Philadelphia Securities Association Management will also Present to Members of the Philadelphia Securities Association

ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q4 2021 Results - Earnings Call Transcript

Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M

SAN CLEMENTE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced participation in the following investor conferences in March:

ReShape Lifesciences Inc. (RSLS) shares closed today at 0.7% above its 52 week low of $1.53, giving the company a market cap of $27M. The stock is currently down 6.1% year-to-date, down 64.8% over the past 12 months, and down 99.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 63.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 77.2% The company's stock price performance over the past 12 months lags the peer average by 595.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Here's three penny stocks to add to your list for next week The post 3 Hot Penny Stocks to Add to Your Watchlist This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto